Okay. Thank you, Suman. Thanks everyone for joining us today for our fourth quarter conference call. Today, and as usual, I will give an update of the current situation at the company, after which, Suman will review our financials in detail. Let me start off again on this quarterly call with Ducommun's Vision 2027 game plan for investors. The strategy and vision were developed coming out of the COVID pandemic over the summer and fall of 2022. We unanimously approved by the Board, the common board in November 2022 and then presented to investors the following month in New York, where we got excellent feedback. Since that time, Ducommun management has been executing the Vision 2027 strategy by increasing the revenue percentage of engineered product and aftermarket content, which finished at 23% for 2024, up from 19% in 2023, consolidating our rooftop footprint in contract manufacturing, continuing the targeted acquisition program, executing our offloading strategy with defense primes and high-growth segments of the defense budget, driving value-added pricing and expanding content on key commercial aerospace platforms. All of us here as well as my fellow board members continue to have a high conviction in the Vision 2027 strategy and financial goals and believe that many catalysts ahead present a unique value creation opportunity for shareholders. The Q4 2024 results are another example of our strategy initiatives working with much more to come in the next few years. Q4 was our 15th consecutive quarter with year-over-year growth in revenue, growing 2.6% over prior year to $197.3 million despite significant headwinds in commercial aerospace build rates, destocking at BA and SPR and the strategic pruning of our non-core industrial business, which I've mentioned in the past. It was also our sixth consecutive quarter above $190 million in revenue. Strong growth in our missile and electronic warfare programs, F-16 and military ground vehicle programs, drove our military space revenue to 5% growth over prior year. Defense business has now been over $100 million in revenues for the fifth time in the last six quarters and remain optimistic about the growth ahead. I also want to point out that three of our top five customers in Q4 were defense primes, and that is consistent with all the quarters in 2024. There is great momentum as we move to build scale at other defense primes such as Northrop Grumman, outside of RTX, our largest customer. Also on the defense side, obviously, a lot of discussion going on for European defense budgets. On January 6, we put out a press release and did announce a major order in Q4 from Bayern-Chemie, a new customer for DCO based in Germany, and is 100% owned by MDBA. This order is in support of NATO and the Patriot PAC-2 missile. Bayern-Chemie makes the rocket motor and came to DCO in Joplin, Missouri for best-in-world cabling solutions. All POs were received in Q4, which totaled over $40 million in cable assemblies and shipments will begin in 2025 through 2030. We're obviously thrilled with this new customer and expect more activity with FMS in 2025. We are very well-positioned. In our commercial aerospace business, we continue to see excellent growth on the A220 program where we make the skins for the entire fuselage. The A220 program grew more than 40% during Q4, and we continue to see growth on other Airbus platforms as well. The commercial rotorcraft business grew over 50% in Q4 over prior year with strong growth on the S-92 platform as well as our BLR fast fin business for helicopters, DCO's most recent acquisition. This growth was partially offset by weakness on Boeing platforms that we all know, as they slowly resumed production after the strike in Q4. Overall, commercial aerospace grew 4% year-over-year in the quarter, we have now grown year-over-year revenue in our commercial aerospace business for 14 consecutive quarters. This is a great story showing the resilience of our business even in a challenging environment with Spirit and Boeing. Gross margins also grew $4.7 million to 23.5% in Q4, up 180 basis points year-over-year from 21.7%, so we continue to realize year-over-year benefits from our strategic value pricing initiatives, productivity improvements, growing the engineered products portfolio of aftermarket and initial restructuring savings, partially offset by some unfavorable product mix and one-time expenses during the quarter. Our Monrovia, California facility is now closed, and our Berryville, Arkansas facility is down to less than 10 people to make capability until the receiving plant in Guaymas, Mexico is certified for the Tomahawk missile program that is expected very soon. We're already seeing cost savings for these facility closures, we'll see those savings be higher as the receiving plants ramp-up production in 2025. Stay tuned. For adjusted operating income margins in Q4, the team delivered 8.2%, which was about flat to the prior year of 8.3%. We continue to be pleased with the growth in our engineered product businesses and are encouraged by the performance in our electronic business this quarter, resulting from the impact of our strategic pricing initiatives. Our restructuring savings during the quarter was offset by lower margins in our Structures business due to unfavorable mix and one-time expenses. Adjusted EBITDA continues to grow compared to last year at 13.8%, up $4.3 million and exceeding $27 million. Great to see. This represents an expansion of 180 basis points above prior year. This continues our year-over-year momentum, we've seen each quarter in 2024, as we work towards the 18% goal in our Vision 2027 plan. GAAP diluted EPS was $0.45 a share in Q4 2024 versus $0.34 a share for Q4 2023. And with the adjustments, diluted EPS was a solid $0.75 a share compared to diluted EPS of $0.70 in the prior year quarter. The higher GAAP and adjusted diluted EPS during the quarter was driven by improved operating income as well as lower interest costs due to our proactive hedging strategy, which took effect in January 2024. The company's consolidated backlog continues to be strong, at $1.06 billion, increasing $17 million sequentially and over $67 million year-over-year despite headwinds from VA. The defense backlog increased $98 million compared to the prior year quarter, and is now at $625 million, with new orders from previously discussed, Bayern-Chemie, the toll missile case, MESA airborne surveillance as well as other platforms. As discussed, we experienced a pause in the order cycle for the toll missile case, but now will be coming back strong with better pricing, we manufacture in our Guaymas Mexico facility, where previously it was produced in Monrovia, California. The commercial aerospace backlog decreased sequentially by $14 million. Full year 2024 revenue grew 3.9% to a record $786 million. Our commercial aerospace business grew 8% in 2024, with strength in Airbus, commercial rotorcraft and business jet platforms, partially offset by weakness on Boeing platforms. Our military and space business grew 4% in 2024, driven by strong performance across missiles, missile defense, radar, naval and F-15 programs, partially offset by weakness on the F-18 and F-35 programs. Our non-core industrial businesses was down 24% as well in 2024 as we continue to selectively prune non-core business, to refocus our portfolio for the long-term. Full year 2024 adjusted EBITDA margins expanded 140 basis points to 14.8%. An excellent performance as we make steady progress towards our VISION 2027 target of 18% EBITDA margins. I'm also delighted to share a significant progress on what I believe number one strategic goal under our VISION 2027 strategy. In December 2022, we set a target of generating 25% plus of our revenues from Engineered Products from 9% in 2017 and 15% in 2022. In 2024, our engineered product revenue was 23% of our total revenue, up from 19% in 2023, positioning us well ahead of the curve achieving our VISION 2027 goal, and we're pushing for a lot more. We achieved this, both through focused investment driving organic growth on our current businesses as well as the BLR acquisition. This tremendous progress and I cannot be happier. As for 2025 revenue, we are positioned to benefit from the expected volume recovery as the year progresses as well as the upcoming certification of three major revenue programs being transferred from our closed plants. We are guiding to mid-single-digit growth for the year, with a flattish first quarter due to destocking and lower build rates, slightly better revenue in Q2, and then renewed strength in the second half of 2025. Now let me provide some additional color on our markets, products and programs. Beginning with our military and space sector, we saw revenues of $109 million, compared to $104 million in Q4 2023. Growth was driven by missile programs such as the MI, the TOW circuit cards along with Next Generation Jammer and the F-16. These are partially offset by weakness on the F-35, Apache and the well-documented F-18. Fourth quarter military space revenue represented 55% of Ducommun's revenue in the period, down from 59%, for the full year back in 2022 and 70% in 2021. We expected this trend and reflects, commercial aerospace getting stronger for DCO, providing good balance. We also ended the fourth quarter with a backlog of $625 million, an increase of $98 million year-over-year, representing 59% of Ducommun's total backlog. Within our commercial aerospace operations, fourth quarter revenue continued to grow, increasing 4% year-over-year to -- excuse me, $82 million, driven mainly by growth on the A220 and S-92 platforms, offset by lower rates on the MAX. As mentioned earlier, we believe a much better story ahead for BA and the MAX. Now the production is ramping up again. We also have high confidence in Kelly Ortberg, and his team. The backlog within our commercial aerospace business was $416 million at the end of the fourth quarter, decreasing $15 million compared to the prior year driven by the Boeing strike. We expect this to recover as production rates ramp up in 2025. Revenues in our industrial business declined by a third to $6 million during Q4 and as we continue to strategically prune non-core business from the portfolio. This will benefit the company in the longer-term as we transition our capacity to our core aerospace and defense platforms. Okay. With that, I'll have Suman review our financial results in detail.